RetinaLyze Launches Advanced Glaucoma Progression AI
RetinaLyze has introduced the Advanced Glaucoma Progression AI. Central to this technology is the 'Glaucoma Index of Progression' (GIP), a tool designed to provide a stable and consistent method for tracking glaucoma progression over time.
Glaucoma, often referred to as the “silent thief of sight,” progresses slowly and without noticeable symptoms until significant vision loss occurs. This makes early detection and ongoing monitoring crucial in preventing irreversible damage. RetinaLyze's Advanced Glaucoma Progression AI addresses this need by offering reliable tracking of glaucoma progression, even when a patient’s measurements fall within normal ranges.
To better understand the importance of tracking glaucoma, RetinaLyze draws an analogy to height measurements. For example, a person who was 1.80 meters tall a year ago but is now 1.70 meters tall remains within the normal height range. However, the decrease indicates a potential underlying issue. Similarly, a patient’s glaucoma status can worsen even when their metrics are still within statistically normal ranges.
The Advanced Glaucoma Progression AI identifies these subtle changes, enabling eye care professionals to detect worsening conditions earlier and respond promptly. This tool simplifies eye screenings and makes the tracking of glaucoma more accessible and efficient for optometrists, ophthalmologists, and other eye care professionals.
One of the key innovations of RetinaLyze's AI solution is its ability to compare changes in both eyes simultaneously. Eye care professionals can now examine Glaucoma Index of Progression (GIP) data alongside visual comparisons of the optic cup and rim sectors in both eyes. This side-by-side analysis provides a comprehensive overview of the optic nerve and surrounding structures, enabling a clearer understanding of how glaucoma progresses or regresses over time, according to RetinaLyze.
Eye care professionals interested in incorporating RetinaLyze’s Advanced Glaucoma Progression AI into their practice can sign up for a free trial.